22.6.2020
- Eight product approvals granted in 2020 with further 26 product submissions pending for approval across the fast-growing SEA region
Newsroom
1.6.2020
LOTUS’ KOREA SUBSIDIARY SECURES EXCLUSIVE DISTRIBUTION AND MARKETING RIGHTS FOR SEROQUEL® and SEROQUEL XR® TO STRENGTHEN THEIR POSITION IN THE CNS FIELD
27.4.2020
LOTUS ANNOUNCES NEW GLOBAL PARTNERSHIPS TO DRIVE GROWTH
14.4.2020
Lotus, An Alvogen Company, Donates Chloroquine to Thailand Ministry of Public Health
26.3.2020
Lotus Pharmaceutical’s Chairman buys shares in the Company
30.12.2019